NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 09/09/2026 10:08
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization276.23 mln
Float6.09 mln
Earnings Date03/16/2027
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.73
Likely reliable
1-Year Forecast
34.00
Attractive
Relative Strength
39
/ 100
Underperforming
Debt / Equity
7.85
Extremely leveraged
Pre-Tax Margin
-27%
Deeply loss-making
Business Description
Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.
